Education
About Us
Working with TipRanks
Follow Us
Inogen (INGN)
NASDAQ:INGN
INGN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.40 - $13.33
Previous CloseN/A
Volume110.44K
Average Volume (3M)298.65K
Market Cap
$190.09M
Enterprise Value$120.66M
Total Cash (Recent Filing)-$15.11M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.38
Next Earnings
Aug 12, 2025EPS Estimate
-0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding26,887,241
10 Day Avg. Volume160,309
30 Day Avg. Volume298,650
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.63
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-3.93
Forecast
1Y Price Target
$8.00Price Target Upside28.21% Upside
Rating ConsensusHold
Number of Analyst Covering4
---
Inogen News
PremiumCompany Announcements
Inogen Inc’s Mixed Q1 2025 Earnings Call Insights
PremiumCompany Announcements
Inogen Reports Improved Q1 2025 Financial Performance
PremiumCompany Announcements
Inogen Inc’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Inogen Reports Strong Revenue Growth in 2024
---
Bulls Say, Bears Say
Bulls Say
Business PerformanceB2B sales beat estimate due to new customer wins and increased business from existing customers.
EarningsINGN's 1Q25 revenue and adjusted EBITDA beat consensus.
Market OpportunityPhilips' exit from the respiratory equipment market in the US has created an opportunity in the SOC category for INGN.
Bears Say
ProfitabilityINGN still has a long way to go to reach sustained non-GAAP EPS profitability.
Sales PerformanceDTC sales missed estimate due to a decline in sales rep headcount.
Tariff ExposureThe company is currently facing challenges related to tariff exposure.
---
Ownership Overview
1.75% Insiders
17.32% Mutual Funds
0.20% Other Institutional Investors
70.56% Public Companies and
Individual Investors
INGN FAQ
What was Inogen’s price range in the past 12 months?
Inogen lowest stock price was $6.40 and its highest was $13.33 in the past 12 months.
What is Inogen’s market cap?
Inogen’s market cap is $190.09M.
When is Inogen’s upcoming earnings report date?
Inogen’s upcoming earnings report date is Aug 12, 2025 which is in 93 days.
How were Inogen’s earnings last quarter?
Inogen released its earnings results on May 07, 2025. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.443 by $0.193.
Is Inogen overvalued?
According to Wall Street analysts Inogen’s price is currently Undervalued.
Does Inogen pay dividends?
Inogen does not currently pay dividends.
What is Inogen’s EPS estimate?
Inogen’s EPS estimate is -0.29.
How many shares outstanding does Inogen have?
Inogen has 26,887,241 shares outstanding.
What happened to Inogen’s price movement after its last earnings report?
Inogen reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.443. Following the earnings report the stock price went down -11.437%.
Which hedge fund is a major shareholder of Inogen?
Currently, no hedge funds are holding shares in INGN
---
Inogen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$8.00 (28.21% Upside)
$8.00 (28.21% Upside)
Blogger Sentiment
Bullish
INGN Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 274.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $125.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.6%
Last 30 Days ▼ 9.6%
Last 30 Days ▼ 9.6%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.66%
12-Months-Change
Fundamentals
Return on Equity
-14.10%
Trailing 12-Months
Asset Growth
-9.20%
Trailing 12-Months
Company Description
Inogen
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
---
INGN Company Deck
---
INGN Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed sentiment. Inogen demonstrated strong revenue growth and improvements in the B2B channel and adjusted EBITDA. The collaboration with UL Medical and reduced operating expenses further contributed positively. However, significant declines in direct-to-consumer sales and rental revenue, coupled with a net loss, indicate challenges that need addressing. Despite positive trends, the balance between highlights and lowlights suggests a cautious outlook.Read More>---
INGN Stock 12 Month Forecast
Average Price Target
$8.00
▲(28.21% Upside)
Technical Analysis
---